Tighe Reardon joined Avalon in 2014. Mr. Reardon has over 22 years of senior finance and technical tax experience ranging from start-ups to large public companies. Mr. Reardon is also CFO of the Accelerator and all portfolio companies within the Accelerator. Mr. Reardon served as Acting CFO of Synthorx (THOR) through its IPO and through its eventual sale to Sanofi, as well as Sitari Pharmaceuticals and Calporta through their sales transactions. Mr. Reardon serves on the board of directors of AristaMD, Cellular Approaches, Nerio, PDI and RQX Pharmaceuticals Inc.
Prior to joining Avalon, Mr. Reardon was the Senior Vice President of Tax and Treasury at DJO Global, Inc., a $1. 2B multinational medical device manufacturer. Additionally, Mr. Reardon acted as the Director of Taxation for Relational Investors, LLC, which at that time was a $7B activist fund.
Mr. Reardon began his career at Arthur Andersen LLP. He has a M.S. in taxation and a B.S. in accounting from San Diego State University. He is a Certified Public Accountant in the State of California.